FEATURED

"There has been far too little effort to raise awareness about atrial fibrillation—the most common arrhythmia and a leading driver of stroke, heart failure, and mortality," said Dr. Yaariv Khaykin, Chief Medical Officer of Myant. "Atrial Fibrillation leads to impaired quality of life and affects productivity, yet many patients don't even realize they have it. Some experience palpitations, others just feel fatigued and attribute it to aging. Many physicians remain unaware of innovations in Atrial Fibrillation management that could transform care. Myant Care360, with direct Atrial Fibrillation assessment referrals, provides unprecedented access to specialized care and early intervention—strategies that have been shown in randomized studies to slow or even reverse the progression of Atrial Fibrillation."

Charm AI Scribe captures the natural dialogue between the patient and provider during a visit and transcribing it in real time.

Smart Reactors, an innovative medical technology company with headquarters in Ireland, is addressing this challenge head-on with its groundbreaking Camouflage™ coating technology.

All around the world, the proliferation of AI tools has decision-makers and business leaders asking each other “What are our needs and how can we use AI to meet them?” The engineers at Kabooxa have solved this contemporary business conundrum by asking another question: “What about an enterprise AI engine that you can leverage to boost performance and ROI?”

DT Research, the leading designer and manufacturer of purpose-built computing solutions for vertical markets, today introduced the DT514 series of All-in-One (AIO) medical computers...

The new partnerships, both of which are effective immediately, further bolster MG America’s leadership status for its two main equipment categories: processing and packaging.

Ms. Yilin (Linda) Wang , CEO of Akso Health Group stated, "The utilization of DeepSeek is a major milestone in AI powered healthcare. By leveraging DeepSeek's technological expertise, we aim to enhance diagnostic accuracy and deliver superior healthcare services to users worldwide."

The contract includes the supply of a Proteus®ONE system and a Quality Assurance package from IBA Dosimetry. Proteus®ONE is the market leading compact proton therapy system, upgradable over time to continue to offer the latest technology to IBA users. The system will also include DynamicARC®[2] beam delivery capabilities, once this feature has received regulatory clearance.